Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Evaluating the impact of daratumumab for the treatment of multiple myeloma according to cytogenetic risk

Dr Luciano Costa - O'Neal Comprehensive Cancer Center at UAB, Birmingham, USA
Evaluating the impact of daratumumab for the treatment of multiple myeloma according to cytogenetic risk ( Dr Luciano Costa - O'Neal Comprehensive Cancer Center at UAB, Birmingham, USA )
10 Jul 2020

MASTER trial updates: Dara-KRd induction, autologous transplantation and MRD response-adapted consolidation in NDMM

Dr Luciano Costa - O'Neal Comprehensive Cancer Center at UAB, Birmingham, USA
MASTER trial updates: Dara-KRd induction, autologous transplantation and MRD response-adapted consolidation in NDMM ( Dr Luciano Costa - O'Neal Comprehensive Cancer Center at UAB, Birmingham, USA )
9 Jul 2020

UKALL2011: Treatment with a tyrosine kinase inhibitor improves outcomes for patients with acute lymphoblastic leukaemia and an ABL-class fusion

Prof Anthony Moorman - Newcastle University, Newcastle upon Tyne, UK
UKALL2011: Treatment with a tyrosine kinase inhibitor improves outcomes for patients with acute lymphoblastic leukaemia and an ABL-class fusion ( Prof Anthony Moorman - Newcastle University, Newcastle upon Tyne, UK )
9 Jul 2020

Phase I/II results: First-line NALIRIFOX in patients with pancreatic ductal adenocarcinoma

Dr Zev Wainberg - Ronald Reagan UCLA Medical Center, Los Angeles, USA
Phase I/II results: First-line NALIRIFOX in patients with pancreatic ductal adenocarcinoma ( Dr Zev Wainberg - Ronald Reagan UCLA Medical Center, Los Angeles, USA )
8 Jul 2020

Long-term disease control in multiple myeloma by in-class transitioning: A community-based study

Dr Robert Rifkin - Rocky Mountain Cancer Centers, Denver, USA
Long-term disease control in multiple myeloma by in-class transitioning: A community-based study ( Dr Robert Rifkin - Rocky Mountain Cancer Centers, Denver, USA )
3 Jul 2020

Venetoclax plus navitoclax in R/R ALL and lymphoblastic lymphoma

Dr Elias Jabbour - MD Anderson Cancer Center, Houston, USA
Venetoclax plus navitoclax in R/R ALL and lymphoblastic lymphoma ( Dr Elias Jabbour -  MD Anderson Cancer Center, Houston, USA )
3 Jul 2020

Treating acute lymphoblastic leukaemia in the era of COVID-19

Dr Elias Jabbour - MD Anderson Cancer Center, Houston, USA
Treating acute lymphoblastic leukaemia in the era of COVID-19 ( Dr Elias Jabbour -  MD Anderson Cancer Center, Houston, USA )
3 Jul 2020

COVID-19 and impact on gynecologic oncology practice in India: Results of a nationwide survey

Dr Anupama Rajanbabu - Amrita Institute of Medical Sciences, Kochi, India
COVID-19 and impact on gynecologic oncology practice in India: Results of a nationwide survey ( Dr Anupama Rajanbabu - Amrita Institute of Medical Sciences, Kochi, India )
3 Jul 2020

The future of PARP inhibitors in prostate cancer

Dr Elena Castro - Spanish National Cancer Research Center, Madrid, Spain
The future of PARP inhibitors in prostate cancer ( Dr Elena Castro - Spanish National Cancer Research Center, Madrid, Spain )
2 Jul 2020

Managing acute myeloid leukaemia during the COVID-19 pandemic

Dr Naval Daver - MD Anderson Cancer Center, Houston, USA
Managing acute myeloid leukaemia during the COVID-19 pandemic ( Dr Naval Daver - MD Anderson Cancer Center, Houston, USA )
1 Jul 2020

Meet the Expert: Daniel Seymour

Daniel Seymour - BIO Ventures for Global Health, Seattle, USA
Meet the Expert: Daniel Seymour ( Daniel Seymour - BIO Ventures for Global Health, Seattle, USA )
1 Jul 2020

Gut microbiome disturbance by antibiotic treatment early in life is sufficient to induce leukaemia in predisposed mice

Dr Carolina Vicente-Dueñas - Institute of Biomedical Research of Salamanca, Salamanca, Spain
Gut microbiome disturbance by antibiotic treatment early in life is sufficient to induce leukaemia in predisposed mice ( Dr Carolina Vicente-Dueñas - Institute of Biomedical Research of Salamanca, Salamanca, Spain )
30 Jun 2020